Wells Fargo
PMVP icon

Wells Fargo’s PMV Pharmaceuticals PMVP Stock Holding History

Wells Fargo’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$10.9K – 7325
2025
Q1 		$10.9K Buy
+10,000
New +$13.6K ﹤0.01% 5869
2024
Q2 		– Sell
-14,491
Closed -$24.6K – 7330
2024
Q1 		$24.6K Buy
14,491
+2,599
+22% +$4.85K ﹤0.01% 5518
2023
Q4 		$36.9K Buy
11,892
+2,360
+25% +$6.25K ﹤0.01% 5386
2023
Q3 		$58.5K Sell
9,532
-5,117
-35% -$35.2K ﹤0.01% 5099
2023
Q2 		$91.7K Buy
14,649
+8,131
+125% +$42.6K ﹤0.01% 5099
2023
Q1 		$31.1K Buy
+6,518
New +$45.9K ﹤0.01% 5431
2022
Q4 		– Sell
-1,888
Closed -$23K – 7651
2022
Q3 		$23K Sell
1,888
-954
-34% -$13.8K ﹤0.01% 5326
2022
Q2 		$41K Buy
2,842
+539
+23% +$7.84K ﹤0.01% 5116
2022
Q1 		$48K Sell
2,303
-8,724
-79% -$154K ﹤0.01% 5679
2021
Q4 		$254K Buy
11,027
+10,990
+29,703% +$266K ﹤0.01% 5128
2021
Q3 		$1K Buy
37
+28
+311% +$894 ﹤0.01% 6770
2021
Q2 		$0 Sell
9
-3,098
-100% -$103K ﹤0.01% 7305
2021
Q1 		$103K Sell
3,107
-3,976
-56% -$157K ﹤0.01% 5471
2020
Q4 		$436K Buy
+7,083
New +$278K ﹤0.01% 4614

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Wells Fargo's PMVP Position: Q2 2025 in Review

Wells Fargo sold out of PMV Pharmaceuticals (PMVP) in Q2 2025, closing a stake of 10,000 shares — an estimated $10.9K sold.

Wells Fargo first reported a position in PMVP in Q4 2020 and held it in 14 quarters. The position peaked at $436K in Q4 2020. 54 funds tracked by Wall St. Rank hold PMVP as of Q2 2025.

  • Wells Fargo reported no remaining PMV Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 10,000 PMV Pharmaceuticals shares in Q2 2025, an estimated $10.9K.
  • Wells Fargo first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • Wells Fargo's PMV Pharmaceuticals position peaked at $436K in Q4 2020.
  • 54 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.